
    
      This study is a prospective, randomized, parallel, controlled, multi-center clinical study of
      Huaren Peritoneal Dialysate and Baxter Peritoneal Dialysate.It aims to investigate the proper
      dialysis dose for Chinese CAPD patients.At the same time,it can evaluate the effectiveness
      and safety of Chinese product Huaren Peritoneal Dialysate and peritoneal dialysis product
      Baxter Peritoneal Dialysate.
    
  